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The bronchial epithelium plays a key role in providing a protective barrier against many environmental substances of
anthropogenic or natural origin which enter the lungs during breathing. Appropriate responses to these agents are
critical for regulation of tissue homeostasis, while inappropriate responses may contribute to disease pathogenesis.
Here, we compared epithelial barrier responses to different pollen species, characterized the active pollen components
and the signaling pathways leading to epithelial activation. Polarized bronchial cells were exposed to extracts of
timothy grass (Phleum pratense), ragweed (Ambrosia artemisifolia), mugwort (Artemisia vulgaris), birch (Betula alba) and
pine (Pinus sylvestris) pollens. All pollen species caused a decrease in ionic permeability as monitored trans-epithelial
electrical resistance (TER) and induced polarized release of mediators analyzed by ELISA, with grass pollen showing the
highest activity. Ultraﬁltration showed that the responses were due to components <3kDa. However, lipid mediators,
including phytoprostane E1, had no effect on TER, and caused only modest induction of mediator release. Reverse-
phase chromatography separated 2 active fractions: the most hydrophilic maximally affected cytokine release whereas
the other only affected TER. Inhibitor studies revealed that JNK played a more dominant role in regulation of barrier
permeability in response to grass pollen exposure, whereas ERK and p38 controlled cytokine release. Adenosine and
the ﬂavonoid isorhamnetin present in grass pollen contributed to the overall effect on airway epithelial barrier
responses. In conclusion, bronchial epithelial barrier functions are differentially affected by several low molecular
weight components released by pollen. Furthermore, ionic permeability and innate cytokine production are
differentially regulated.
Introduction
The airway epithelium is the first site of contact for inhaled
environmental materials (noxious gases, anthropogenic and natu-
ral particulates, including pathogens) and its barrier properties
are crucial for regulation of innate barrier immunity and control
of tissue homeostasis. Epithelial barrier functions can be divided
into 3 types: physical, chemical and immunological.1,2 The phys-
ical barrier arises from the propensity of epithelial cells to elabo-
rate a range of cell-cell contacts including tight junctions,
adherens junctions and desmosomes that link with the cytoskele-
ton to form a robust sheet-like structure. The epithelial barrier is
selectively permeable due to the presence of sub-apical tight junc-
tions, which are formed by transmembrane and intracellular pro-
teins that link to the actin cytoskeleton. These junctions form
around the whole perimeter of each cell, forming a continuous
belt-like structure that regulates paracellular permeability to ions
and macromolecules, as well as the polarity of the epithelium.3
Located below the tight junctions are the adherens junctions that
also link to the actin cytoskeleton, and desmosomes which link
to intermediate filaments. These two types of junctions do not
directly seal the space between epithelial cells, but they are critical
for providing the adhesive force to ensure the integrity of the cell
layer. Many proteins are involved in the regulation of the junc-
tional complexes and these not only play a role in adhesion, but
also in transcriptional regulation to modulate cell function.4
The chemical barrier of the pseudostratified airway epithelium
is elaborated by the goblet cells and submucosal glands that
secrete mucus, a fluid containing hydrated gel-forming mucins
and a range of host defense and cytoprotective molecules, includ-
ing anti-microbial molecules, anti-proteases and antioxidants.
This mucus traps and inactivates inhaled particles and facilitates
their clearance via the mucociliary escalator. In addition to these
physical and chemical barriers, airway epithelial cells play a key
role in immune surveillance, contributing to innate immunity by
the secretion of immuno-stimulatory and modulatory mediators
including cytokines, chemokines, growth factors and lipid media-
tors.2 Critical to function of this immunological barrier are the
tight junctions that determine apical-basolateral polarity and vec-
torial cytokine release.
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It has been hypothesized that abnormalities in airway epithe-
lial barrier properties are central to many lung diseases, including
bronchial asthma.5 Genome wide association studies have shown
that many of the asthma susceptibility genes are expressed in the
airway epithelium.6 Furthermore, epidemiological studies suggest
that environmental interactions with the airway epithelium in
early life, e.g. pollution and viral infections, increase susceptibil-
ity for development of asthma.7,8 Exposure to airborne allergen
carriers such as pollen has also been linked to an increased risk of
asthma9 and, airborne pollen is able to trigger asthma
exacerbations.10
After inhalation, pollen grains become hydrated on the aque-
ous surface of the airway epithelium and, within a short period
release various substances including allergens and many low
molecular weight substances.11 It has been shown that pollen
associated lipid mediators, like phytoprostane E1 (PPE1), have
immuno-modulatory properties on dendritic cells favoring TH2-
mediated T cell responses.12 The relevance of lipids in the regula-
tion of epithelial barrier function is supported by a study showing
that lipoxin A4 increases the physical barrier properties of airway
epithelial cells.13 Furthermore, peroxisome proliferator-activated
receptor (PPAR) g is a known receptor of many lipid mediators
including prostaglandins14 and it has been shown that PPARg is
involved in the regulation of the tight junction complex.15 Previ-
ously we showed that grass pollen extracts do not disrupt the
physical barrier of primary human bronchial epithelial cells
(PBECs) differentiated at the air-liquid interface, however they
did stimulate polarized release of mediators; furthermore, we
observed a different pattern of mediator responses in differenti-
ated PBECs derived from patients with severe asthma.16 The aim
of this study was to compare epithelial barrier responses to differ-
ent pollen species, characterize the active pollen components and
the signaling pathways leading to epithelial activation.
Results
Effect of pollen on bronchial epithelial barrier functions
First, we characterized the effect of pollen extracts from differ-
ent plant species on the barrier functions of polarized 16HBE
cells. The physical barrier properties were monitored by measur-
ing the transepithelial electrical resistance (TER) and the immu-
nological barrier by analyzing polarized release of mediators by
ELISA. Stimulation of polarized 16HBE cells with extracts of
pollen from timothy grass (Phleum pratense), ragweed (Ambrosia
artemisifolia), pine (Pinus sylvestris), birch (Betula alba) or mug-
wort (Artemisia vulgaris) resulted in a significant increase in TER
(Fig. 1A). The maximum increase was observed between 1–2 h
after stimulation and this was maintained over 24h. Interestingly,
an increase in TER was detected even though protease activity
could be detected in the pollen extract, with Ambrosia showing
the highest protease activity (Fig. S1), but still causing a signifi-
cant increase in TER across the epithelial layer. Furthermore, all
pollen species induced polarized release of GM-CSF mainly to
the apical compartment (Fig. 1B) with the effects of Phleum
(timothy grass) and Pinus pollen extracts reaching statistical
significance. IL-8 release was also observed, however this only
reached significance for Phleum pollen extracts which stimulated
IL-8 release into both apical and basolateral compartments
(Fig. 1B).
Since pollen extract from timothy grass showed the highest
activity, we further characterized its effects on bronchial epi-
thelial barrier functions. The increase in TER induced by
grass pollen extract was concentration-dependent (Fig. 2A)
and the release of GM-CSF (Fig. 2B) and, to a lesser extent,
IL-8 (Fig. 2C) also showed a concentration-dependent rela-
tionship. Since an increase in TER is mostly likely correlated
with a tightening of the physical barrier mediated by tight
junction proteins, we analyzed the cellular distribution of
ZO-1 and actin filaments by fluorescence microscopy. As
shown in Figure 3, ZO-1 was exclusively localized at the api-
cal side of the polarized 16HBE cell layer and treatment with
pollen resulted in more distinct ZO-1 staining, with all apical
cells being surrounded by a continuous ring of ZO-1. Fur-
thermore, staining of the actin filaments was less diffuse in
the treated cells implying increased organization of the actin
cytoskeleton in response to pollen extract.
Figure 1. Effect of pollen extract derived from different species on the
barrier functions of bronchial epithelial cells. Polarized 16HBE cells were
exposed to an extract equivalent of 5 mg/ml pollen. (A) Trans-epithelial
resistance (TER) measured over time. TER is normalized to tD 0 h directly
after stimulation (n D 5). (B) Apical and basolateral release of GM-CSF
and IL-8 induced by pollen after 24 h measured by ELISA (n D 5–7).
Mean §SEM; *: p  0.05 compared to untreated control (2-way ANOVA
Bonferroni’s multiple comparison).



























Pollen extract induces a polarized release of mediators from
epithelial cells
Since the integrity of the physical barrier was not disrupted by
exposure to pollen extracts, we analyzed the vectorial release of
several immunological mediators into the apical and basolateral
compartments of our cell culture model. This showed that grass
pollen extract stimulated polarized 16HBE cells to release GM-
CSF, CCL20, IL-8 and TNF-a. As shown in Figure 4, the
release of GM-CSF and CCL20 is highly polarized. GM-CSF
was mainly released to the apical compartment, whereas CCL20
was released to the basolateral compartment after treatment with
grass pollen extract. In contrast, the release of IL-8 after pollen
treatment was increased similarly in both apical and basolateral
compartments. The concentration of released TNF-a in
untreated cells was comparable in the apical and basolateral com-
partments. After treatment with pollen extract, the release of
TNF-a was increased mainly in the apical compartment.
Characterization of active compounds in grass pollen extract
In order to characterize the active compound(s) in the pollen
extract that were capable of affecting the epithelial barriers, grass
pollen extract was separated into fractions lower and higher than
3kDa by ultrafiltration. As shown in Fig. 5A, only the <3kDa
fraction caused an increase in the TER which was comparable to
total pollen extract. Similarly, the <3kDa fraction also caused
apical release of GM-CSF, which was not observed in the
>3kDa fraction (Fig. 5B). These data suggest that substances in
the pollen of a molecular weight lower than 3kDa are responsible
for the effects observed on the epithelial barrier.
Previously, it has been shown that low molecular weight sub-
stances isolated from pollen can modulate immune responses
mediated by dendritic cells, and the pollen-associated lipid
Figure 2. Concentration-dependent effect of grass pollen extract (PE) on
bronchial epithelial barrier functions. (A) Trans-epithelial resistance (TER)
is normalized to t D 0 h (n D 5–8). Release of GM-CSF (B) and IL-8 (C)
induced by grass pollen analyzed by ELISA (n D 5–8). Mean §SEM; *:
p  0.05 compared to untreated control (Mann-Whitney).
Figure 3. Cellular localization of the tight junction protein ZO-1 in bron-
chial epithelial cells after exposure to grass pollen extract (PE). Polarized
16HBEs were exposed for 24 h to an equivalent of 5mg/ml pollen and
stained by immunoﬂuorescence for ZO-1 (red) and the actin ﬁlament
(green). Nuclei are shown in blue. Z-projections and orthogonal views




























mediator phytoprostane E1 (PPE1) was identified as active com-
pound.17 Therefore we determined the effect of PPE1 on bron-
chial epithelial barrier functions. Since barrier improving effects
of lipoxin A4 have been reported previously, we also included
this lipid mediator into our studies. Similarly, as peroxisome pro-
liferator activated receptor gamma (PPARg) plays a critical role
in the control of epithelial barrier functions15 and can be acti-
vated by natural products, as well as fatty acids and prostanoids,
we tested the involvement of PPARg in pollen-mediated barrier
functions. However, treatment of polarized 16HBE cells with
PPE1 or lipoxin A4 did not alter the ionic permeability (Suppl.
Fig. 2A, B). Similarly treatment with the PPARg agonist ciglita-
zone did not affect the TER (Suppl. Fig. 2C); Furthermore, the
PPARg antagonist T0070907 caused only a modest reduction of
the pollen-induced increase in TER which failed to reach statisti-
cal significance.
We also assessed the effects of the lipid mediators on cytokine
production. PPE1 weakly modulated the immunological barrier
properties by showing a trend for a concentration-dependent
increase in apical release of GM-CSF (Suppl. Fig. 3A). However,
the observed mediator release induced by PPE1 was below the
level induced by total pollen extract. Furthermore, release of IL-8
and TNF-a was not significantly affected by any PPE1
concentration (Fig. S3B, C). Similarly, the effects of lipoxin A4
on apical GM-CSF release and basolateral IL-8 release were weak
and did not reach statistical significance (Suppl. Fig. 4A, B).
Interestingly, the PPARg antagonist T0070907 significantly
enhanced apical and basolateral release of IL-8, and showed a
similar trend for apical release of GM-CSF. This was modestly
increased by co-exposure to grass pollen (Fig. S4A,B). The effects
of ciglitazone on GM-CSF or IL-8 release (Fig. S4A,B) were not
significant.
Since our data suggested that lipid mediators were not the
main class of substances released from pollen that altered epithe-
lial barrier functions, we additionally analyzed the effect of the
flavonoid isorhamnetin on bronchial epithelial barrier function.
As shown in Supplemental Figure 5, isorhamnetin did not alter
the physical barrier properties but showed a significant increased
apical release of GM-CSF and IL-8, almost comparable to that
of pollen extract.
As a series of known lipid mediators did not mimic the effects
of grass pollen, we further characterized the active components of
grass pollen, by separating the <3kDa fraction of pollen by
reverse phase chromatography to isolate substances according to
their hydrophobicity. As shown in Figure 6, the unbound,
hydrophilic components (flow through fraction) caused only a
Figure 4. Polarized release of IL-8, GM-CSF, CCL20 and TNF-a induced by grass pollen extract (PE). Polarized 16HBEs were exposed for 24 h to an equiva-
lent of 5 mg/ml pollen and the apical and basolateral release of GM-CSF (A), IL-8 (B), TNF-a (C) and CCL20 (D) were analyzed by ELISA (n D 9; CCL20 api-
cal n D 4)). Mean §SEM; *: p  0.05 compared to untreated control (Wilcoxon).



























slight increase in TER in the first 2h whereas the weakly hydro-
phobic wash fraction caused a similar effect on the TER com-
pared to the <3kDa fraction before separation. In contrast,
apical release of GM-CSF was most strongly induced by the flow
through fraction, but a smaller stimulatory effect was also
observed in the wash fraction.
In summary, separation of the <3kDa fraction of grass pollen
extract by reverse phase chromatography indicated that the sub-
stances responsible for inducing mediator release and altering the
ionic barrier properties are mainly hydrophilic molecules, since
little binding to the reverse phase cartridge was observed. Fur-
thermore, the data suggest that the ionic and immunological bar-
rier properties are differentially regulated, since the TER was
mainly increased by the wash fraction whereas GM-CSF release
was mainly induced by the flow through fraction. Further analy-
sis by mass spectrometry failed to define the molecular species
responsible for these effects.
MAPK signaling pathways are involved in the regulation of
barrier functions
As our data implied differential regulation of the barrier
responses to pollen extracts, we hypothesized that different intra-
cellular signaling mechanisms would be involved in these
responses. Since MAPK signaling pathways are among the main
signaling pathways involved in regulation of epithelial barrier
properties, we analyzed the effect of specific pharmacological
inhibitors of these pathways on pollen extract mediated
responses.16,18 As shown in Figure 7A, B, the increase in TER
induced by pollen extract was completely abolished by the JNK
inhibitor SP600125. The p38 inhibitor SB203580 was also a
potent inhibitor of the pollen extract but its effect decreased over
time and the TER started to recover. The ERK1/2 inhibitor
U0126 showed a partial reduction in the pollen extract mediated
TER increase, which only reached statistical significance in the
first 4 h, but failed to reach statistical significance at 6 h and 8 h
when the TER started to recover. In contrast, pollen-induced api-
cal release of GM-CSF was completely inhibited by the ERK1/2
inhibitor U0126 and the p38 inhibitor SB203580 while the JNK
inhibitor SP600125 had little effect (Fig. 7C). Pollen-induced
apical release of IL-8 and CCL20 was reduced by the p38 inhibi-
tor SB203580, while the ERK1/2 and JNK inhibitors were with-
out effect (Fig. 7D, E). The apical release of TNF-a showed a
trend for reduction with the ERK1/2 and p38 MAPK inhibitors,
but this failed to reach statistical significance (Fig. 7F). In sum-
mary, pollen affected the epithelial ionic permeability barrier pri-
marily through the JNK MAPK signaling pathway, whereas
cytokine secretion was primarily mediated by the ERK1/2 and
p38 signaling pathways.
Adenosine receptor involvement in pollen-induced barrier
modulation.
We previously identified the water-soluble nucleoside adeno-
sine in grass pollen extract and showed that the function of den-
dritic cells is modulated by pollen-derived adenosine.19
Therefore, we tested if the A2A and A2B adenosine receptors were
involved in pollen-mediated changes of bronchial epithelial bar-
rier function. As shown in Figure 8, the A2B receptor antagonist
caused a small reduction of the pollen-mediated increase in TER
while the A2A receptor antagonist had no effect. Consistent with
this, addition of adenosine to epithelial cultures caused a small
increase in TER which was also blocked by the A2B receptor
antagonist. However, the pollen-induced release of IL-8 and
TNF-a was not affected by adenosine receptor antagonists (Fig.
S6). These data indicate that adenosine present in grass pollen
may contribute to the pollen-mediated improved physical barrier
in airway epithelial cells. However, other yet unidentified sub-
stances are also involved and regulate the physical and immuno-
logical barrier properties of airway epithelial cells.
Figure 5. Low molecular weight substances of grass pollen alter bron-
chial epithelial barrier functions. Grass pollen extract (PE) was separated
by ultraﬁltration into fractions <3kDa and >3kDa. Polarized 16HBEs
were stimulated apically with an equivalent of 5 mg/ml pollen. (A)
Trans-epithelial resistance (TER) over time (n D 7). TER is normalized to
tD0 h. Mean §SEM; *: p  0.05 compared to untreated control (Wil-
coxon). (B) Apical and basolateral release of GM-CSF over 24 h analyzed





























In this study we found that exposure of bronchial epithelial
cells to soluble components derived from pollens of grass, birch,
ragweed, mugwort or pine resulted in a decrease in ionic perme-
ability (i.e. increase in TER) of the epithelial barrier, even though
protease activity was detectable in the extracts. Additionally, all
pollen species induced polarized release of inflammatory media-
tors by the epithelium. Of the pollens tested, grass pollen derived
substances showed the highest potential to affect bronchial epi-
thelial barrier functions. Using ultrafiltration we demonstrated
that low molecular weight substances below <3kDa were respon-
sible for altered barrier functions in bronchial epithelial cells.
Using ultra-performance liquid chromatography and mass spec-
trometry, we have previously shown that fraction comprises thou-
sands of substances.19 Through use of reverse phase
chromatography we determined that there are likely multiple
components that affect the epithelium as the fraction that was
most potent for stimulation of mediator release was ineffective in
regard to decreasing ionic per-
meability. Consistent with this,
the effects of the grass pollen
extract on ionic permeability and
cytokine release appeared to be
due to differential activation of
several pathways. JNK inhibitors
markedly suppressed the change
in ionic permeability over the
duration of the experiment,
whereas the p38 and ERK1/2
pathways appeared to contribute
only to the early response to
grass pollen substances. In con-
trast, release of GM-CSF and IL-
8 was affected by ERK1/2 and
p38 pathway inhibitors with rel-
atively little contribution of JNK
to these responses. Together,
these data suggest that the physi-
cal and immunological barrier
properties of the bronchial
epithelium are differentially
regulated.
Involvement of the JNK
pathway in the regulation of epi-
thelial cellular junctions has been
shown previously, although
effects are cell type, stimulus and
duration-specific.20 For example,
in intestinal epithelial cells JNK
mediated disassembly of junc-
tions via re-organization of the
cytoskeleton and formation of
contractile actin rings after cal-
cium depletion.21 In contrast, in
human bronchial epithelial cells
JNK mediated an increase in transepithelial resistance after acti-
vation of the epidermal growth factor receptor (EGFR) and
upstream Rac1 signaling pathways.22 Furthermore, it has been
shown that activation of the JNK pathway increased the expres-
sion of tricellulin, a tight junction protein located at tricellular
junctions, and increased physical barrier properties in epithelial
cells.23 MAPK signaling pathways also regulate the release of
inflammatory mediators like IL-8. While activation of the ERK
pathway is thought to slightly increase IL-8 gene expression, acti-
vation of the p38 pathway stabilizes the mRNA resulting in
increased protein expression.24 In this study, using the 16HBE
cell line model we showed the involvement of p38 MAPK signal-
ing pathways in the regulation of apical IL-8 release, which con-
firms our previous data using primary differentiated bronchial
epithelial cells.16
Using fully differentiated human PBECs, we previously
showed that the TER of differentiated PBECs was increased
in the presence of pollen derived substances.16 Since we
observed the same effect of pollen on the physical barrier
Figure 6. Characterization of substances released by grass pollen that alter the barrier functions of bronchial
epithelial cells. The low molecular weight fraction (<3kDa) of pollen extract (PE) was separated by chromatog-
raphy and resulting fractions were used to stimulate polarized 16HBE cells apically. Trans-epithelial resistance
(TER) was measured 2 h after stimulation and normalized to t D 0 h (n D 5). After 24 h apical release of GM-
CSF was analyzed by ELISA (n D 4–9). Mean §SEM; *: p  0.05 compared to untreated control (Mann-
Whitney).



























properties in this study, the bronchial epithelial cell line
16HBEs was considered to be an appropriate model to ana-
lyze the effect of pollen substances on the barrier properties
in more detail. Additionally, in our cell line model the
pollen-induced changes in mediator release corresponded to
the differentiated human PBECs model, with both models
showing increased apical and basolateral release of IL-8 and
just basolateral release of CCL20 in response to pollen.
Figure 7. Involvement of MAPK signaling pathways in the regulation of bronchial epithelial barrier functions. Polarized 16HBEs were pre-treated for
30min with MAPK speciﬁc inhibitors (UO126: ERK1/2; SB203580: p38; SP600125: JNK) and subsequently exposed to an equivalent of 5mg/ml pollen. (A)
Trans-epithelial resistance (TER) was measured over time after pollen exposure and normalized to t D 0h (n D 5). (B) TER at time point of 8h (nD 5). After
24h of exposure release of apical GM-CSF (C), apical IL-8 (D), basolateral CCL20 (E) and apical TNF-a (F) was analyzed by ELISA (n D 4–5). Mean §SEM; *:




























After inhalation, pollen grains are hydrated on the airway
mucosa and they release a multitude of substances in a short
period of time; these substances range from proteins like allergens
and proteases, to carbohydrates and lipid mediators.11 There is
evidence that proteases released by pollen are able to disrupt the
physical barrier of the epithelium.25,26 However, these studies
used rather high pollen concentrations. In our model, the pollen
concentrations are closer to natural exposure situations during
the pollen season and despite detectable protease activity in the
pollen extracts we did not observe any disruption of the physical
barrier. Moreover, the increase in TER was mediated by low
molecular weight substances and their effect may dominate over
the effects of proteases. Potential candidate compounds which
are able to alter airway epithelial barrier functions are pollen-asso-
ciated lipid mediators, like PPE1.
11 Previously, it has been shown
that PPE1 is able to modulate dendritic cell function favoring a
TH2 mediated immune response.
17 In this study we showed that
PPE1 did not significantly affect either cytokine release or the
physical barrier of bronchial epithelial cells. Furthermore,
although the endogenous lipid mediator lipoxin A4 has been
shown to modulate airway epithelial barrier functions by increas-
ing the physical barrier properties,13 we could not confirm this
effect on TER, or any effect on cytokine release.
Epithelial barrier functions can be regulated by PPARg, a
member of the nuclear hormone receptor family and a recep-
tor for many lipid mediators like prostaglandins.14 It has
been shown that PPARg agonists improve the physical barrier
properties of nasal epithelial cells by inducing expression of
tight junction proteins.15 Additionally, activation of PPARg
is associated with an anti-inflammatory role in the lung.27–29
Furthermore, it has been shown that the LPS-induced release
of IL-12 by dendritic cells is inhibited by pollen-derived
PPE1 via a PPARg-dependent mechanism to support TH2
polarization.17 In the current study, we showed that PPARg
activation makes only a limited contribution to the pollen-
induced increase in TER, since the PPARg antagonist
T0070907 had only a small suppressive effect on the pollen-
induced TER response, and the PPARg agonist ciglitazone
alone had no effect. Of note, the PPARg antagonist caused
an increased release of GM-CSF and IL-8 by bronchial epi-
thelial cells in the absence or presence of pollen extract. This
can be explained by the interaction of PPARg and NF-kB,
where reduced PPARg activity results in increased NF-kB
activity,30 with the effect of stimulating inflammatory cyto-
kine release.
In addition to lipid mediators, pollen extract contains many
flavonoids, polyphenolic molecules which are ubiquitously pres-
ent in plants. Biological effects have been described for many fla-
vonoids, ranging from anti-inflammatory, anti-oxidant to anti-
microbial.31 Of relevance to the current study, the flavonoid
quercetin has been reported to improve physical barrier functions
in epithelial cells.32,33 In this study we tested the effect of iso-
rhamnetin, a methylated metabolite of quercitin identified in
Phleum pratense pollen,34 onto the epithelial barrier properties.
While the physical barrier properties were unaffected, isorhamne-
tin induced the release of GM-CSF and IL-8 to a level that was
comparable to pollen extract. Since our results suggest, that the
physical and immunological barrier properties are regulated by
Figure 8. Effect of adenosine receptor antagonists on pollen-induced
increase in physical barrier properties of airway epithelial cells. Polarized
16HBEs were pre-treated for 60 min with A2A and A2B adenosine recep-
tor antagonists and subsequently exposed to pollen extract (PE) equiva-
lent of 5 mg/ml pollen. Physical barrier properties were monitored by
TER measurements over time (A). As control, adenosine and receptor
antagonists were used and TER measurements after 24 h are shown (B).
(n D 5); Mean §SEM; *: p  0.05 compared to pollen or adenosine treat-
ment (paired Student’s t-test)



























different mechanisms and substances, flavonoids present in pol-
len extract are a strong candidate for the activation of the immu-
nological barrier.
Separation of the low molecular weight fraction of grass pollen
extract by reverse phase chromatography showed that substances
with a hydrophilic nature are responsible for the observed effects
on epithelial barrier functions. In addition to flavonoids, poten-
tial candidate substances with a low molecular weight are purine
and pyrimidine nucleosides. Adenosine, a purine nucleoside
identified in grass pollen, has been shown to have immune-mod-
ulatory function on dendritic cells and thus influence T cell
polarization.19 Using endothelial cells, a barrier improving effect
of adenosine has previously been show.35 In the current study we
showed that the adenosine A2B receptor antagonist partially
reduced the pollen induced increase in physical barrier functions
indicating that adenosine may be one of many substances in pol-
len extract that influence the physical barrier properties of airway
epithelial cells. However, other yet unidentified substances might
be more effective or interact with each other to affect the epithe-
lial barrier.
In summary we have shown that a variety of hydrophilic
pollen substances, many yet to be identified, are able to dif-
ferentially modulate the physical or immunological barrier
properties of bronchial epithelial cells. Potential candidates
that contribute to the overall effect of pollen extract on the
airway barrier functions include the flavonoid isorhamnetin
which modulates the immunological barrier and adenosine
which affects the physical barrier. By using high performance
liquid chromatography to further separate the active com-
pounds it may be possible to identify specific components
with distinct effects on epithelial cells rather than the mixed
effect observed with the total pollen extract. Identification of
specific substances in pollen altering the physical or immuno-
logical barrier of bronchial epithelial cells should increase our
understanding of the regulatory mechanisms of epithelial bar-
rier functions. Furthermore, identification of natural products
that improve the physical barrier function might potentially
be of benefit in the therapy of airway diseases where the
physical barrier is dysfunctional.
Material and Methods
Cell culture
The human bronchial epithelial cell line, 16HBE14o- (a gift
from Prof. DC. Gruenert, San Francisco, USA), was maintained
in minimum essential medium (MEM) with Glutamax and sup-
plemented with 10% foetal bovine serum and penicillin/strepto-
mycin (Life technologies) (growth medium); cell culture flasks
were coated with PureCol collagen I (Advanced BioMatrix). For
experiment, 16HBE cells were cultured in collagen coated Trans-
well permeable supports (diameter 6.5 mm, polyester mem-
brane with 0.4 mm pores, Corning Life Sciences). Cells were
seeded at a density of 1.5 £ 105 cells in 200 ml growth medium;
the basolateral compartment contained 500 ml of the same
medium. Medium exchange was carried out every 2–3 days.
After 6 days, growth medium was exchanged and the apical
medium was replaced by MEM without supplements. On day 7
the transepithelial resistance (TER) was measured using a
EVOM voltohmmeter (World Precision Instruments); experi-
ments were carried out when the cultures were polarized, having
TERs higher than 1000 V.
Aqueous pollen extracts (APE)
Pollen from Timothy grass (Phleum pratense), Ragweed
(Ambrosia artemisifolia), Mugwort (Artemisia vulgaris), Birch
(Betula alba) and Pine (Pinus sylvestris) were obtained from Aller-
gon. Extracts of pollen were prepared by resuspending pollen
grains in MEM without supplements at 30 mg/ml. After incuba-
tion at 37C with agitation for 30 min, extracts were centrifuged,
sterile filtered and stored in aliquots at ¡80C until use.
Stimulation of cells
Polarized 16HBE cells were stimulated apically with pollen
extract. Concentrations cited in the results refer to the weight of
pollen grains per ml before the extraction process. Directly after
stimulation, TER was measured and monitored over time. TER
measurements were normalized against the TER directly after
stimulation (t D 0h). After 24 h, apical and basolateral superna-
tants were harvested and clarified by centrifugation; mediator
release was analyzed by ELISA (GM-CSF ELISA: eBioscience;
CXCL8/IL-8, CCL20 and TNF-a DuoSet ELISA kits: R&D
Systems). Involvement of mitogen-activated protein kinase
(MAPK) signaling pathways in the regulation of 16HBE barrier
functions was investigated by using specific pharmacological
inhibitors. U0126 was used as an inhibitor of the ERK1/2 path-
way, SB203580 for blocking the p38 pathway and SP600125 for
inhibiting the JNK pathway (all inhibitors from Sigma). Cells
were treated apically with 25 mM of each inhibitor 30min before
and during APE stimulation. DMSO was used as a vehicle con-
trol. Where tested, PPE1 (kindly provided by Prof. Martin J.
M€uller, University of W€urzburg, Germany), lipoxin A4 (Enzo
Life Sciences), isorhamnetin (Sigma) and adenosine (Sigma)
were diluted in MEM and applied apically. T0070907 was used
as a PPARg antagonist and ciglitazone as PPARg agonist (Cay-
man Chemical). SCH-442416 and MRS-1754 (Sigma) were
used as an adenosine A2A and A2B receptor antagonist,
respectively.
Fluorescence microscopy
After 24 h of stimulation cells were fixed with 4% paraformal-
dehyde, permeabilised with 0.1% Triton X-100, blocked with
1% BSA in PBS and triple stained with an AlexaFluor647 labeled
mouse monoclonal anti-ZO-1 antibody (clone ZO1-1A12),
phalloidin-AlexaFluor488 and SytoxOrange (all from Life tech-
nologies). Stained membranes were mounted on slides using Pro-
Long Gold antifade reagent (Life technologies) and analyzed
with a LSM6000 microscope (Leica Microsystems). On z-stacks,
a deconvolution was performed using Leica Application Suite





























Isolation and characterization of pollen derived substances
Timothy grass pollen extract was fractionated by ultrafil-
tration using centrifugal filter units with a molecular weight
cut-off of 3kDa (Millipore). Low molecular weight substances
of the <3kDa fraction were further separated by reverse
phase chromatography using BondElut Plexa cartridges (Agi-
lent Technologies). Briefly, the <3kDa fraction was made
alkaline with 2% NH4OH, applied to the conditioned car-
tridge and the flow through collected. After washing the car-
tridge with 2% NH4OH, bound substances were eluted with
100% methanol and isopropanol. Each fraction was collected
and lyophilized for mass spectrometry (see below) and assess-
ment of bioactivity. In the latter case, the fractions were
redissolved in half the volume of the original extract in
MEM to account for the loss during the separation process
and used for cell stimulation.
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